ICU-acquired Colonization and Infection Related to MDR in Immunocompromised Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

759 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-11-07

Study Completion Date

2021-12-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the number of immunocompromised patients hospitalized in the intensive care units (ICU) is increasing. They are at higher risk of colonization and/or infection with multi-resistant bacteria (MDR). However this risk is not well characterized. ICU acquired infections related to MDR are associated with increased morbidity and mortality. The aim of this study is to compare the incidence of ICU-acquired colonization and ICU-acquired infection related to MDR between immunocompromized and immunocompetent patients. The risk factors for ICU-acquired colonization and ICU-acquired infections, and their impact on outcome will also be evaluated and compared between immunocompromised and immunocompetent patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Immunosuppression and Intensive Care Unit-acquired Multidrug-resistant Bacteria

NCT06652126

Critically-ill Patients

NOT_YET_RECRUITING

Risk Factors for Multidrug Resistant Bacteria at ICU Admission

NCT05983861

Multi Drug Resistant Bacteria

UNKNOWN

Linezolid-resistant Staphylococcus Epidermidis in ICU and Risk Factors Analysis

NCT03140410

Health Care Associated Infection Antibiotic Resistant Strain Infection Transmission

UNKNOWN

Impact of Tubing Colonization on the Incidence of Central Venous Catheter Infection

NCT06019897

UNKNOWN

Incidence of Colonization by Multidrug-resistant Organisms in Mechanically Ventilated Patients With Severe COVID-19

NCT05293418

COVID-19 Bacterial Infections Colonization, Asymptomatic

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Immunocompromised Host Critical Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Expected ICU stay \> 48 hours
* All patients (immunocompromised or immunocompetent).

Exclusion Criteria

* Patients aged \< 18 years
* Refusal to take part in the study
* ICU-stay \< 48 hours
* Non availability of initial MDR or subsequent screening
* Participation in another study that could interfere with the risk of ICU-acquired colonization and infection with MDR bacteria

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No